.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Treatment Options in Myelodysplastic Syndromes

EP. 1: Heterogeneity and Presentation of MDS

November 18th 2020

EP. 2: Ensuring an Accurate Diagnosis

November 18th 2020

EP. 3: Challenges of MDS Management

November 18th 2020

EP. 4: Disease-Course Differentiation: Low Risk and High Risk

November 18th 2020

EP. 5: IPSS/IPSS-R Reliability in Various Disease Settings

November 18th 2020

EP. 6: The Role of Supportive Care

November 18th 2020

EP. 7: Initiating First-Line Treatment

November 18th 2020

EP. 8: The Role of Hypomethylating Agents and Transplantation

November 18th 2020

EP. 9: Overview of Luspatercept-aamt as MDS Treatment

November 18th 2020

EP. 10: The Future of MDS Management

November 18th 2020